Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Bene fits and rationale for exercise during cancer therapy
Morten Quist
*
, Lee W. Jones
*
Corresponding author for this work
UCSF - Centre for Health Research
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bene fits and rationale for exercise during cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Exercise Training
100%
Cancer Therapy
100%
Benes
100%
Cancer Diagnosis
80%
Lancet
60%
Adjuvant Therapy
40%
Exercise Therapy
40%
Peppercorn
40%
Adverse Events
20%
Attitude Change
20%
Quality of Life
20%
Meta-analysis
20%
Systematic Meta-analysis
20%
Immune System
20%
Effective Therapy
20%
Dogma
20%
Patient-reported Outcomes
20%
Oncology
20%
Structured Exercise
20%
Extant Literature
20%
Exercise Intensity
20%
Regular Exercise
20%
VO2peak
20%
Poor Survival
20%
Late Effects of Cancer Treatment
20%
Traditional Exercise
20%
Cardiorespiratory Fitness
20%
Primary Therapy
20%
Adherence Rate
20%
Exercise Guidelines
20%
Clinical Medicine
20%
Human Following
20%
Moderate-to-vigorous Intensity
20%
Cancer Survivorship
20%
Exercise Prescription
20%
Prescription Guidelines
20%
American College of Sports Medicine
20%
Nursing and Health Professions
Malignant Neoplasm
100%
Cancer Diagnosis
100%
Cancer Therapy
100%
Practice Guideline
66%
Adjuvant Therapy
66%
Kinesiotherapy
66%
Systematic Review
33%
Quality of Life
33%
Meta Analysis
33%
Adverse Event
33%
Patient-Reported Outcome
33%
Cardiorespiratory Fitness
33%
Survivorship in Cancer Care
33%
Medicine and Dentistry
Exercise
100%
Cancer Therapy
100%
Malignant Neoplasm
60%
Cancer Diagnosis
60%
Adjuvant Therapy
40%
Kinesiotherapy
40%
Attitude
20%
Quality of Life
20%
Adverse Event
20%
Meta-Analysis
20%
Systematic Review
20%
Survivorship in Cancer Care
20%
Oncology
20%
Immune System
20%
Patient-Reported Outcome
20%
Exercise Intensity
20%
Cardiorespiratory
20%
Sports Medicine
20%
Clinical Medicine
20%
Late Effect of Cancer
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Adverse Event
11%